These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19523152)

  • 1. The influence of class II transactivator and interleukin-6 polymorphisms on the production of antibodies to donor human leucocyte antigen mismatches in renal allograft recipients.
    Martin J; Worthington J; Harris S; Martin S
    Int J Immunogenet; 2009 Aug; 36(4):235-9. PubMed ID: 19523152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
    Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
    Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection.
    Zibar L; Wagner J; Pavlinić D; Galić J; Pasini J; Juras K; Barbić J
    Scand J Immunol; 2011 Apr; 73(4):319-24. PubMed ID: 21204904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
    Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
    Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
    Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.
    Eikmans M; de Canck I; van der Pol P; Baan CC; Haasnoot GW; Mallat MJ; Vergunst M; de Meester E; Roodnat JI; Anholts JD; van Thielen M; Doxiadis II; de Fijter JW; van der Linden PJ; van Beelen E; van Kooten C; Kal-van Gestel JA; Peeters AM; Weimar W; Roelen DL; Rossau R; Claas FH
    Transplantation; 2012 Sep; 94(5):478-85. PubMed ID: 22892990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.
    Singh R; Manchanda PK; Kesarwani P; Srivastava A; Mittal RD
    Clin Transplant; 2009; 23(4):490-8. PubMed ID: 19486347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients.
    Womer KL; Magee CC; Najafian N; Vella JP; Milford EL; Sayegh MH; Carpenter CB
    Clin Transplant; 2008; 22(6):754-9. PubMed ID: 18647327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs.
    Jin Y; Ruiz P
    Transplant Proc; 2008 Jun; 40(5):1329-32. PubMed ID: 18589098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation.
    Gautreau C; Suberbielle C; Andrade J; Charron D
    Clin Transpl; 2006; ():502. PubMed ID: 18365411
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.
    Gebel HM; Moussa O; Eckels DD; Bray RA
    Hum Immunol; 2009 Aug; 70(8):610-7. PubMed ID: 19375473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
    Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
    Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.